10-Q/A: ASHS Restates Q3, Faces Going Concern Doubt Over Debt Default

American Shared Hospital Services restates its Q3 2025 financial statements, reclassifying $8.6 million in debt to current liabilities, raising substantial doubt about its ability to continue as a going concern.

Summary

• American Shared Hospital Services (ASHS) filed an amended Quarterly Report on Form 10-Q/A to restate its unaudited condensed balance sheet for the quarter ended September 30, 2025.
• The restatement reclassifies $8,631,000 of debt under credit agreements with Fifth Third Bank and DFC from long-term to current liabilities.
• This reclassification was triggered by an Event of Default with Fifth Third Bank for failing to maintain $5,000,000 in unrestricted domestic cash and a potential Event of Default under the DFC Loan.
• The company's liquidity condition, coupled with the potential acceleration of debt obligations, raises substantial doubt about its ability to continue as a going concern.
• For the three months ended September 30, 2025, total revenues increased by $172,000 to $7,171,000, and the net loss attributable to ASHS improved to $(17,000) from $(207,000) in the prior year.
• For the nine months ended September 30, 2025, total revenues increased by $1,083,000 to $20,354,000, but the net loss attributable to ASHS was $(922,000), a significant decline from net income of $3,514,000 in the prior year (which included a $3,942,000 bargain purchase gain).
• Direct patient services revenue increased significantly by $2,848,000 (36.48%) for the nine-month period, driven by the Rhode Island acquisition and the Puebla, Mexico facility.
• Leasing segment revenue decreased by $1,765,000 (15.4%) for the nine-month period, primarily due to lower PBRT volumes and the expiration of three Gamma Knife customer contracts.
• The company had negative working capital of $5,211,000 at September 30, 2025, compared to positive working capital of $15,853,000 at December 31, 2024, largely due to the debt reclassification.
• Management has identified a material weakness in internal controls over financial reporting due to insufficient personnel and resources, with remediation efforts underway including new hires in finance and accounting.

Sentiment

Score: 2

Explanation: The filing presents a highly negative outlook due to the reclassification of significant debt to current liabilities, an explicit Event of Default by a major lender, and the company's own admission of 'substantial doubt about its ability to continue as a going concern.' While some revenue segments show growth, the severe liquidity crisis and internal control weaknesses overshadow any operational positives, indicating a precarious financial position.

Positives

• Total revenues increased by $172,000 (2.46%) for the three months ended September 30, 2025, compared to the prior year.
• Net loss attributable to American Shared Hospital Services improved by $190,000 for the three months ended September 30, 2025, compared to the prior year.
• Direct patient services revenue increased by $347,000 (9.41%) for the three months and $2,848,000 (36.48%) for the nine months ended September 30, 2025, driven by recent acquisitions and new facility operations.
• The company completed an equipment upgrade to a Gamma Knife Esprit in Peru in June 2025, leading to increased volume from short treatment times.
• New Chief Financial Officer appointed in December 2024, and additional staff hired in finance and revenue cycle management to address internal control weaknesses.

Negatives

• The company faces substantial doubt about its ability to continue as a going concern due to debt covenant defaults and potential acceleration of payment obligations.
• A significant portion of debt, $8,631,000, was reclassified from long-term to current liabilities, severely impacting the balance sheet and working capital.
• Working capital deteriorated significantly, moving from a positive $15,853,000 at December 31, 2024, to a negative $5,211,000 at September 30, 2025.
• Net loss attributable to American Shared Hospital Services for the nine months ended September 30, 2025, was $(922,000), a substantial decline from net income of $3,514,000 in the prior year (excluding the prior year's bargain purchase gain, the loss still worsened).
• Leasing segment revenue decreased by $175,000 (5.28%) for the three months and $1,765,000 (15.4%) for the nine months ended September 30, 2025, primarily due to lower PBRT volumes and expired Gamma Knife contracts.
• PBRT fractions decreased by 102 for the three months and 669 for the nine months ended September 30, 2025, indicating lower utilization.
• The company has a material weakness in internal controls over financial reporting due to insufficient personnel and resources.

Risks

• Fifth Third Bank and DFC could accelerate all payment obligations under the Credit Agreements due to the existing defaults, which the company would not have sufficient cash to satisfy.
• Inability to refinance or negotiate an extension to the Credit Agreement would adversely impact liquidity and jeopardize the company's ability to satisfy commitments over the next twelve months.
• The company's debt agreements contain restrictive covenants that limit its flexibility in operating its business, including limitations on incurring additional indebtedness, dispositions, mergers, and distributions.
• Failure to obtain adequate financing or financing on satisfactory terms for future projects could significantly impair business growth and ability to respond to challenges.
• The company's operations and profitability may be materially adversely affected by the limited market for its capital-intensive services and the impact of lowered federal reimbursement rates.
• Technological advances and the risk of equipment obsolescence pose a threat to the company's significant investment in proton beam radiation therapy business.
• Breaches in security of information technology could adversely affect the company's operations.
• The small and relatively illiquid market for the company's stock may affect its ability to raise capital or for investors to trade shares.

Future Outlook

The company is currently in discussions with Fifth Third Bank regarding a waiver and an amendment to the Credit Agreement, but there are no assurances regarding the outcome. Similarly, there is no assurance that DFC will provide a waiver if an event of default is triggered under the DFC Loan. The company intends to finance substantially all of its future equipment commitments, but there is no assurance that financing will be available on acceptable terms. The Newco Guadalajara facility is not expected to begin treating patients until the second quarter of 2026.

Management Comments

• "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report."
• "Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report."
• "The Company believes it will be able to refinance or negotiate an extension to the Credit Agreement, however, if the Company is unable to do so, the Company's liquidity will be adversely impacted and the Company's ability to satisfy all of its commitments over the next twelve months in accordance with their current terms would be jeopardized."
• "Despite management's belief, as long as the Company remains in default under the Credit Agreements, Fifth Third and DFC could accelerate all payment obligations under the Credit Agreements."
• "If such acceleration were to occur, the Company would not have sufficient cash on hand to satisfy the accelerated payment obligations."
• "Management has determined that the Company's liquidity condition raises substantial doubt about the Company's ability to continue as a going concern, should Fifth Third and DFC accelerate all payment obligations."
• "The primary element of our remediation plan [for internal control weaknesses] can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects."

Industry Context

The company operates in the specialized medical equipment leasing and direct patient services sector for radiosurgery and advanced radiation therapy. While the direct patient services segment shows growth, reflecting potential demand for cancer treatment services, the leasing segment faces challenges from lower PBRT volumes and contract expirations. The industry is capital-intensive, requiring significant financing for equipment, and is subject to changes in reimbursement rates (e.g., CMS rates for Gamma Knife and PBRT treatments). The company's international expansion in Mexico, Peru, and Ecuador indicates a strategy to diversify geographically and patient populations, though these markets can be influenced by local legislation and socio-economic factors.

Comparison to Industry Standards

• The company's reliance on a few key lenders (Fifth Third Bank, DFC) for substantial debt financing is common in capital-intensive medical equipment sectors, but the breach of a cash-maintenance covenant highlights a significant liquidity risk that could be atypical for a healthy, publicly traded company.
• The reported CMS reimbursement rates for Gamma Knife ($7,645 in 2025) and PBRT ($578-$1,276 in 2025) provide a benchmark for revenue per procedure, but the filing does not offer specific comparisons to how these rates impact profitability relative to industry peers or global benchmarks.
• The acquisition of the RI Companies and expansion into Mexico and Ecuador for direct patient services aligns with a trend among medical technology providers to diversify revenue streams beyond pure equipment leasing, moving towards integrated service delivery. However, the financial performance of these new ventures needs to be assessed against established players in those regions.
• The material weakness in internal controls over financial reporting, particularly concerning personnel and resources, suggests a governance and operational standard below that expected of larger, more mature public companies in the healthcare sector, which typically have robust financial control environments.

Management Changes

Corporate Governance

Legal Proceedings

• None mentioned in Item 1. Legal Proceedings.

Related Party Transactions

• Equipment purchases and de-install costs from Elekta (19% owner of GKF subsidiary) totaled $1,243,000 for Q3 2025 and $4,412,000 for YTD 2025.
• Costs incurred to maintain equipment from Elekta totaled $278,000 for Q3 2025 and $729,000 for YTD 2025.
• Total related party transactions were $1,521,000 for Q3 2025 and $5,141,000 for YTD 2025.
• Commitments to purchase and install two Esprit units, two LINACs, and service related equipment from Elekta totaled $11,045,000 as of September 30, 2025.
• Related party liabilities (accounts payable, asset retirement obligation, and other accrued liabilities) were $1,471,000 at September 30, 2025, compared to $2,270,000 at December 31, 2024.

Stakeholder Impact

• **Shareholders**: Significant negative impact due to the 'going concern' doubt, reclassification of debt, and potential acceleration of obligations, which could lead to substantial share price volatility and erosion of value.
• **Creditors (Fifth Third Bank, DFC)**: Increased risk of default and potential acceleration of loans. Fifth Third has already suspended the Revolving Loan Commitment.
• **Employees**: Uncertainty regarding the company's financial stability could impact employee morale and retention, especially in finance and accounting roles where new hires are being made.
• **Customers (Hospitals, Patients)**: Potential disruption to services if the company faces severe liquidity issues or if equipment financing becomes unavailable, though direct patient services are currently growing.
• **Suppliers (Elekta, Mevion, Solutech, Mobius Imaging)**: Risk of delayed or non-payment for equipment purchases and maintenance services, especially given the related party transactions with Elekta.

Next Steps

• Continue discussions with Fifth Third Bank regarding a waiver and an amendment to the Credit Agreement.
• Monitor DFC's response to the potential Event of Default under the DFC Loan.
• Secure financing for $7,884,000 in commitments to purchase and install two Leksell Gamma Knife Esprit Systems and two Linear Accelerator systems, anticipated in Q1 or Q2 2026 or later.
• Continue implementing the remediation plan for the material weakness in internal controls over financial reporting, including hiring sufficient personnel and improving financial reporting processes.
• Newco Guadalajara facility is expected to begin treating patients in the second quarter of 2026.

Key Dates

Recommendation

The filing reveals a critical financial situation, with the company explicitly stating 'substantial doubt about its ability to continue as a going concern.' This is driven by a material debt covenant breach with Fifth Third Bank, leading to the reclassification of $8.6 million in debt to current liabilities and the suspension of its revolving credit line. The potential for lenders to accelerate all payment obligations, which the company admits it cannot meet with current cash, creates an immediate and severe liquidity crisis. While some revenue segments show growth, the fundamental financial stability is severely compromised. A seasoned investor would view this as an extremely high-risk situation with significant downside potential, warranting a strong sell recommendation until these fundamental going concern issues are definitively resolved and the company demonstrates a clear path to financial stability.

Keywords

Medical Equipment Leasing, Radiation Therapy, Gamma Knife, Proton Beam Therapy, SEC Filing, 10-Q/A, Restatement, Debt Default, Going Concern, Financial Reporting, Healthcare Services, ASHS, Fifth Third Bank, DFC Loan, Liquidity, Covenant Breach